Marker Therapeutics Inc (MRKR) 시세

Come on, Vera, let’s get it going!!!

As I recall the old management team bought on the open market a couple of years back. Went straight down hill from there but always wondered what went so wrong? Even still, it’d be good to see.

Canaccord Genuity Initiates Marker Therapeutics at Buy With $8 Price Target
07:22 AM EST, 03/05/2025 MT Newswires

Canaccord Genuity Initiates Marker at Buy with $8 Price Target. Anyone have their comments?

Is that 25,000 shares for each patient he enrolled?

The Board of Directors have approved stock options of 50,000 shares for the CEO. how about buying some shares in the open market?

Vera has generated crickets. “Off the shelf” appears to be out the window.

No mystery. Research for researches sake on the backs of sucker public retail to benefit BP along with handsome executive salaries and perks. Always been that way in the biotech space but even worse these days.

I thought that is was supposed to be better, quicker, cheaper and safer than CAR-T with no cytokine release syndrome.

Was anybody able to access the presentation that is supposed to be taking place now?

Well that's a partial answer to a question I've had for decades: Who buys obvious penny stock crap like this. "It’s still a mystery to me what MRKR actual goal was"

Your right Phantom we all didn’t dig deep enough to figure out the actual science of this treatment. I dove in because of the so called patents that they acquired on the treatment which obviously didn’t mean anything. I take full responsibility for falling for a bio tech stock with false promises. It’s still a mystery to me what MRKR actual goal was. I thought it was an over the counter’therapy for different cancer related issues. I hadn’t looked at the share price in a long time so I willed myself to look. Not surprised in the least where it’s fallen to.

GREAT NEWS: Conference Call today. We may get an update on the two patients that they first dosed two years ago.
OH HAPPY DAY, wouldn't that be Special.

Maybe we’ll find they added a patient to the trial. 🙄…

Professor Vera, sell this company!!!

Any chance we get new information at the conference today?

My only problem is that NEA ain't as old as me, so after my 25+ years in TPIV/MRKR they can afford to have more patience that me, mine has been running thin for these last few years.

NEA is a "true" venture firm with serious Silicon Valley roots. This is what they do. This company just happens to be public. They support their deals if there is an argument to do so.

I assume Baker Bros. is a hedge fund at heart, wants losers off their books if need be, etc. That said, I remember thinking, "They are being disciplined," when it happened. It was the smart move.

As a side note, it looks like the PI for OTS in AML is using lymphodepletion. If I read that correctly, that seems new (I think) and is consistent with a company mention that they did seem to see the benefit of that. Prior, they consistently said they didn't think it was necessary. (I'm running fast, so anyone should correct me if I have the facts wrong.)

Holy S--T, I was not aware of that. That kind of sucks.
I think for this post I am not going to click on the green bull emoji.

Baker brother bought in at the initial merger. Ended up selling their shares and their warrants expired worthless. Unlike NEA I would assume Baker brothers learned their lesson.

Yep, being that I never heard of Alyeska, Blue Owl, or Hudson Bay, it doesn't really inspire too much added confidence. Now if I see Baker Brothers come in with 5 or 10 million, I would take that as a good sign. I follow them just to see what their new investments are every quarter, they seem to do really well, I followed them into SMMT (SMMT worked well in China beating Keytruda, we will see about what happens in the US).

No real opinion. They made the same mistake all of us did putting money here too early. Their just able to pump more money into it in hopes of making something back. Don't care about the new investors much. They won't have a hand in if the company actually gets their shit together.

Phantom, Any opinion on NEA increasing their shares by 52% to 2.8 million dollars and Alyeska, Blue Owl, and Hudson Bay coming in with a combined 3 million (more than NEA currently has)?
Thanks

Looks like they are pivoting to include an HMA for AML...?
https://clinicaltrials.gov/study/NCT06552416
https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-reports-mt-401-non-clinical-data-aml-cells

I believe the Baylor data for lymphoma was also about 40% also. There is a research report "out there" articulating it, but I don't have time to dig it up now. If they went head to head with CAR-T and were equivalent, this would be a blockbuster because 40% is of people ineligible or who failed CAR-T. However, that test is very unlikely to happen.

I do not recall off the top of my head what the 401 results were but I don't believe the response rates were better than the 601 results. That being said we can't really compare the two because they are targeting two different types of cancers.

Phantom, do you recall the results from the the 401 Lymphoma trial. So far the 601 trial has a 44% complete response rate and a 77% objective response rate. I'm asking if the 601 formula appears to be any better than the 401 formula?

Any guesses?? I’m going to take this as a positive.

Despite the price that has been going down. This just reported, a tiny bit interesting, NEA increases shares by 52%,
plus 3 new large buyers, which means ????
Owner Name Date Shares Held Change (Shares) Change (%) Value (In 1,000s)
Nea Management Company, Llc 12/31/2024 1,625,678 554,250 51.73% $2,796
Alyeska Investment Group, L.P. 12/31/2024 915,591 915,591 New $1,575
Blue Owl Capital Holdings Lp 12/31/2024 554,250 554,250 New $953
Hudson Bay Capital Management Lp 12/31/2024 331,670 331,670 New $570

Funny the mod chooses to leave your post up? Nearly everything I’ve predicted has come true, in case you didn’t notice. So, destroying by facts, I guess. But at least you rightfully got kicked off the NWBO board.

LC2020. Your over 10 years history of trying to help destroy NWBO is well documented with or without adding that peace to your recent post!!.. ........>If True> ............. KARMA watching...


748884
of 748884
…I should’ve included “If true

Well, you, me and everybody else may just have to give it another year ...........
........... or 5 ........
........... or 10.

It's close but I'll vote Peter.

Me!!! for buying this stock😥 I can’t believe I’ve given a hope,

Who is worse, Peter Huang or Juan Vera?

Terrible news for our local biomed shills. notice
MRKR's fall.

Here come DEEP Trump Cuts to biomed research. Front page news everywhere. Way overdue.

LC2020 - Irrelevant posts as usual for a buck or two$. SAD...

Looks like same bias here as on NWBO. 

LC2020 -
This comment below you posted is very RICH (lol) coming from someone who posts antagonistically for a living... DELUTIONAL..

"""If you folks are ever ready to have a big boy conversation on the pros and cons of such, I’ll be glad to provide my opinion.:"::

LOL

…They call it “Research for researches sake along with great salaries provided by poor unknowing retail for the benefit of big Pharma”.

Here we go again! Raise millions then drive the company into the ground then reverse merge / reverse split, and then do it all over again. Management gets rich while shareholders go broke. They’ve already done the deal so…

Noticed it said that no other matters were up for consideration. So much for shareholder activism. Sigh.

Proxy filings…

https://www.sec.gov/Archives/edgar/data/1094038/000110465925009098/tm253006-2_def14a.htm

https://www.sec.gov/Archives/edgar/data/1094038/000110465925009098/tm253006-2_def14a.htm

Marker Therapeutics
2450 Holcombe Blvd, Suite BCM-A, MS: BCM251
Houston, TX 77021

NOTICE OF SPECIAL MEETING OF STOCKHOLDERS

To Be Held On March 21, 2025

Dear Stockholder:
You are cordially invited to attend the Special Meeting of Stockholders of Marker Therapeutics, Inc., a Delaware corporation (the “Company”). The meeting will be held on Friday, March 21, 2025 at 9:00 a.m. Central Time and will be a virtual stockholder meeting through which you can listen to the meeting, submit questions and vote online. You must register for the virtual meeting via https://web.viewproxy.com/markertherapeutics/2025SM no later than 11:59 p.m. Eastern Time on Thursday, March 20, 2025. The meeting will be held for the following purposes:
1.
To approve, in accordance with Nasdaq Listing Rule 5635(d), the issuance of the shares issuable upon exercise of (i) Series A Warrants to acquire 5,031,250 shares of Common Stock (the “Private Placement Warrants”) and (ii) Series B Warrants to acquire 3,247,445 shares of Common Stock (the “Pre-Funded Warrants”, and together with the Private Placement Warrants, the “Warrants”).

2.
To conduct any other business properly brought before the meeting.

These items of business are more fully described in the Proxy Statement accompanying this Notice.
The record date for the Special Meeting is January 27, 2025. Only stockholders of record at the close of business on that date may vote at the meeting or any adjournment thereof.


Click above links for complete filings…

Hey Vera, SELL THIS COMPANY!

LC2020. Over 16000 post in over 12 years!! Think DISCOVERY!!!

He is a successful business person, woke up (pun intended) and said, do I really want to be ignored. He walked away and will come back to buy us for ten cents on the dollar. The good news, there's none for us.

https://scitechdaily.com/scientists-unlock-the-secret-to-supercharged-cancer-fighting-t-cells/

I was told it was DEI's fault. Do I win? Thank you.

Any guesses out there, on why he resigned and what’s going to happen next? The correct guess wins a prize.lol

It’s important to keep this guy’s name at the top just for accountability’s sake. Don’t let the link just disappear.

Dr. Huseynov:

https://www.moomoo.com/news/post/44817152/ladenburg-thalmann-maintains-marker-therapeutics-mrkrus-with-buy-rating-raises?level=2&data_ticket=1737645360288002

https://stockanalysis.com/analysts/aydin-huseynov/

https://www.benchmarkcompany.com/the-benchmark-company-expands-its-biotechnology-focus-with-the-addition-of-dr-aydin-huseynov-and-dr-okechukwu-linton/

Thank you 👍

Hopefully they sell the tech long before that because management were a total failure for shareholders, and now it feels like their remnants turned into a One man show.